Results 31 to 40 of about 143,361 (253)

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.

Clinical Microbiology and Infection, 2021
SCOPE In 2009, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) published the first treatment guidance document for Clostridioides difficile infection (CDI). This document was updated in 2014.
J. van Prehn, E. Reigadas, E. Vogelzang, E. Bouza, A. Hristea, B. Guery, M. Krutova, T. Norén, F. Allerberger, J. Coia, A. Goorhuis, T. V. van Rossen, R. Ooijevaar, K. Burns, B. R. Scharvik Olesen, S. Tschudin-Sutter, M. Wilcox, M. Vehreschild, F. Fitzpatrick, E. Kuijper   +19 more
semanticscholar   +1 more source

Does Fecal Microbiota Transplant Have a Role in Treating Recurrent Clostridioides difficile Infection in Rural Hospitals?

Frontiers in Public Health, 2021
Clostridioides difficile infection possesses a significant economical burden, specifically in the inpatient and rural settings. Fecal Microbiota Transplant has been used for treatment of recurrent Clostridioides difficile but its utility is limited by ...
Krishna Vedala, Philip Sobash, Parth Shah, Gilbert-Roy Kamoga   +3 more
doaj   +1 more source

Editorial for the Special Issue: Clostridium difficile

Microorganisms, 2021
Clostridium difficile (reclassified as Clostridioides difficile [...]
Łukasz M. Grześkowiak
doaj   +1 more source

Analysis of the impact of secondary prophylaxis on recurrence in critically ill adults

SAGE Open Medicine, 2020
Introduction: Clostridioides (formerly Clostridium ) difficile infection recurrence in patients re-exposed to antibiotics for treatment of a non- Clostridioides difficile infection is high at approximately 33%. Low-dose per os vancomycin (e.g. 125 mg q12 
Kathryn A Connor, Kelly M Conn
doaj   +1 more source

Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut

Nature Microbiology, 2023
Bile salt hydrolases encoded by the gut microbiome shape the bile acid pool, including microbial conjugated bile acids, which impact Clostridioides difficile infection in the murine gut.
M. H. Foley, Morgan E. Walker, A. Stewart, Sarah O’Flaherty, Emily C. Gentry, Shakshi Patel, Violet V. Beaty, Garrison B. Allen, Meichen Pan, J. B. Simpson, Caroline D. Perkins, Molly E. Vanhoy, Michael K. Dougherty, Sarah K. McGill, Ajay S. Gulati, P. Dorrestein, E. Baker, M. Redinbo, R. Barrangou, C. Theriot   +19 more
semanticscholar   +1 more source

VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2023
Importance The effect of rationally defined nonpathogenic, nontoxigenic, commensal strains of Clostridia on prevention of Clostridioides difficile infection (CDI) is unknown.
T. Louie, Y. Golan, S. Khanna, D. Bobilev, N. Erpelding, Candida Fratazzi, M. Carini, Rajita Menon, Mary M. Ruisi, J. Norman, J. Faith, B. Ollé, Minran Li, J. Silber, D. Pardi   +14 more
semanticscholar   +1 more source

Clostridioides difficile peptidoglycan modifications

Current Opinion in Microbiology, 2022
The cortex and peptidoglycan of Clostridioides difficile have been poorly investigated. This last decade, the interest increased because these two structures are highly modified and these modifications may be involved in antimicrobial resistance. For example, C.
Coullon, Héloïse, Candela, Thomas
openaire   +4 more sources

In Vitro Activity of Omadacycline and Five Comparators against Contemporary Ribotypes of Clostridioides difficile in Stockholm, Sweden

Microbiology Spectrum, 2021
Clostridioides difficile infection represents a growing clinical challenge. The new compound omadacycline is a potential treatment alternative, as many antibiotics have limited activity or are rarely used due to costs and side effects.
Angela Camporeale, Chaitanya Tellapragada, Jelena Kornijenko, Carl Erik Nord, Christian G. Giske   +4 more
doaj   +1 more source

Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).

Cochrane Database of Systematic Reviews, 2023
BACKGROUND Clostridioides difficile (formerly known as Clostridium difficile) is a bacterium that can cause potentially life-threatening diarrheal illness in individuals with an unhealthy mixture of gut bacteria, known as dysbiosis, and can cause ...
N. Minkoff, Scheherzade Aslam, Melissa Medina, E. Tanner‐Smith, J. Zackular, S. Acra, M. Nicholson, A. Imdad   +7 more
semanticscholar   +1 more source

Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI

BMC Infectious Diseases, 2021
Clostridioides difficile is a Gram-positive anaerobic bacterium, which causes Clostridioides difficile infection (CDI). It has been recognised as a leading cause of healthcare-associated infections and a considerable threat to public health globally ...
Elaine Finn, F. Andersson, M. Madin-Warburton   +2 more
semanticscholar   +1 more source